Keybanc Maintains Overweight on ICU Medical, Lowers Price Target to $164
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $180 to $164.
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and lowers the price target from $180 to $164.